SOLA Biosciences ^{For Profit}

SOLA Biosciences is a company dedicated to developing gene-therapies for patients with neurodegenerative diseases such as ALS and Huntington's disease. Their technology, called "JUMP70," selectively reduces abnormal disease-causing proteins that form toxic clumps in the neuron cells of patients with these diseases. SOLA currently has nine more clinical candidates with JUMP70 technology to target other challenging diseases. The company works with researchers, medical doctors, foundations, collaborators, and investors to make this technology available for patients and their loved ones in need. Contact info: N/A